Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 239S · 10 late239 trades$59.22M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Krishnamurthy Balaji (A)Chief Financial Officer | UBERUber Technologies, Inc Tax withholding | F | $24K 341 sh |
| Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Flees Lori AnnDirector, President & CEO |  VVVVALVOLINE INCGrant or award | A | $974 36 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 5 | Aufderhaar DavidChief Financial Officer |  SFIXStitch Fix, Inc.Option exercise | M | — 43.9K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Hazelbaker JillSee Remarks | UBERUber Technologies, Inc Option exercise | M | — 352 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Krishnamurthy Balaji (A)Chief Financial Officer | UBERUber Technologies, Inc Option exercise | M | — 567 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Krishnamurthy Balaji (A)Chief Financial Officer | UBERUber Technologies, Inc Option exercise | M | — 687 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Macdonald AndrewSee Remarks | UBERUber Technologies, Inc Option exercise | M | — 1,133 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Krishnamurthy Balaji (A)Chief Financial Officer | UBERUber Technologies, Inc Option exercise | M | — 885 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Budur KumarCHIEF MEDICAL OFFICER |  HRMYHarmony Biosciences Holdings, Inc.Option exercise | M | — 900 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Krishnamurthy Balaji (A)Chief Financial Officer | UBERUber Technologies, Inc Option exercise | M | — 885 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 4 | Offer OrChief Executive Officer |  SMWBSIMILARWEB LTD.Open-market sale · 10b5-1 plan | SELL | $254K 30.4K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 4 | Offer OrChief Executive Officer | SMWBSIMILARWEB LTD. Open-market sale · 10b5-1 plan | SELL | $384K 45.7K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 4 | Lo FrancisChief People Officer | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $225K 7,869 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 3 | Kumar MukulPRESIDENT, ENGINEERING |  PUBMPubMatic, Inc.Derivative conversion · 10b5-1 plan | C | — 8,000 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 3 | Lo FrancisChief People Officer | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 23.4K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 3 | Kumar MukulPRESIDENT, ENGINEERING | PUBMPubMatic, Inc. Derivative conversion · 10b5-1 plan | C | — 8,000 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 3 | Azar Samak LChief Legal Officer |  GFSGLOBALFOUNDRIES Inc.Open-market sale · 10b5-1 plan | SELL | $15K 335 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 3 | Lo FrancisChief People Officer | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 15.6K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 3 | Kumar MukulPRESIDENT, ENGINEERING | PUBMPubMatic, Inc. Option exercise · 10b5-1 plan | M | $17K 8,000 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 3 | Wang LingkeDirector, President |  LIFEEthos Technologies Inc.Open-market sale · 10b5-1 plan | SELL | $12K 315 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 3 | Colis Peter GeorgeDirector, CEO and Secretary | LIFEEthos Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $12K 315 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 3 | Song EstherSee Remarks |  SYNASYNAPTICS IncOpen-market sale · 10b5-1 plan | SELL | $5,836 63 sh | Sep 18, 2026 traded Sep 18, 2026 |
| 3 | Sullivan Christopher RyanChief Financial Officer |  AVTXAvalo Therapeutics, Inc.Option exercise · 10b5-1 plan | M | $122K 12.4K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 2 | Sousa Mauad BrunoDirector | AUGOAura Minerals Inc. Derivative conversion | C | $37K 400 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 2 | Lo FrancisChief People Officer | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $62K 15.6K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 2 | Lo FrancisChief People Officer | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $190K 23.4K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 1 | Navratil TomasCHIEF DEVELOPMENT OFFICER |  GKOSGLAUKOS CorpOpen-market sale · 10b5-1 plan | SELL | $77K 460 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 1 | Matsuda MasaruSee Remarks |  ARQTArcutis Biotherapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $92K 3,674 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 1 | Navratil TomasCHIEF DEVELOPMENT OFFICER | GKOSGLAUKOS Corp Open-market sale · 10b5-1 plan | SELL | $57K 345 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 0 | Song EstherSee Remarks | SYNASYNAPTICS Inc Tax withholding · 10b5-1 plan | F | $13K 138 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 0 | von Ahn LuisDirector, President & CEO, Co-Founder, 10% Owner |  DUOLDuolingo, Inc.Derivative conversion · 10b5-1 plan | C | — 5,252 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 0 | Navratil TomasCHIEF DEVELOPMENT OFFICER | GKOSGLAUKOS Corp Open-market sale · 10b5-1 plan | SELL | $40K 234 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 0 | Colis Peter GeorgeDirector, CEO and Secretary | LIFEEthos Technologies Inc. Derivative conversion · 10b5-1 plan | C | — 23.3K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 0 | Colis Peter GeorgeDirector, CEO and Secretary | LIFEEthos Technologies Inc. Derivative conversion · 10b5-1 plan | C | — 23.3K sh | Sep 18, 2026 traded Sep 18, 2026 |
| 0 | Navratil TomasCHIEF DEVELOPMENT OFFICER | GKOSGLAUKOS Corp Open-market sale · 10b5-1 plan | SELL | $17K 103 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 0 | Colis Peter GeorgeDirector, CEO and Secretary | LIFEEthos Technologies Inc. Derivative conversion · 10b5-1 plan | C | — 23.3K sh | Sep 18, 2026 traded Sep 18, 2026 |
| 0 | von Ahn LuisDirector, President & CEO, Co-Founder, 10% Owner | DUOLDuolingo, Inc. Derivative conversion · 10b5-1 plan | C | — 23.0K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 0 | Sullivan Christopher RyanChief Financial Officer | AVTXAvalo Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 12.4K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 0 | Navratil TomasCHIEF DEVELOPMENT OFFICER | GKOSGLAUKOS Corp Open-market sale · 10b5-1 plan | SELL | $688 4 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 0 | Navratil TomasCHIEF DEVELOPMENT OFFICER | GKOSGLAUKOS Corp Open-market sale · 10b5-1 plan | SELL | $20K 120 sh | Sep 18, 2026 traded Sep 16, 2026 |